» Articles » PMID: 32851798

Lactate Induced Up-regulation of KLHDC8A (Kelch Domain-containing 8A) Contributes to the Proliferation, Migration and Apoptosis of Human Glioma Cells

Overview
Journal J Cell Mol Med
Date 2020 Aug 28
PMID 32851798
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Glioma is a common type of malignant brain tumour with high mortality and relapse rate. However, the molecular mechanisms of glioma development have not been clarified. Differentially expressed genes in normal brain tissues and glioma tissues, low-grade and high-grade gliomas were screened out with GEO database analysis. We found that KLHDC8A (Kelch domain-containing 8A) expression level was significantly increased in high-grade glioma tissues and that high KLHDC8A expression was closely related with poor prognosis. Function assays indicated that KLHDC8A knockdown inhibited proliferation, migration and invasion, blocked the cell cycle and promoted apoptosis in glioma cells. Mechanistically, KLHDC8A regulated various functions in glioma by directly mediating Bcl2, BAX, p21, CDK2, MMP2 transcription and ERK and P38 MAPK activation. KLHDC8A overexpression enhances glioma tumorgenesis such as cell proliferation, migration and invasion. The ERK and P38 MAPK which activated by KLHDC8A overexpression could be reversed by U0126 and SB203580, respectively. Meanwhile, stimulation of lactate which produced by glycolysis is responsible for induction of KLHDC8A expression. Collectively, we demonstrated that KLHDC8A plays an important role in tumorgenesis of glioma, suggesting that it is a promising prognostic marker and a potential therapy target for the treatment of glioma.

Citing Articles

Evaluating KLHDC8A as a biomarker for glioma: impact on survival and proliferation through the Wnt/β-catenin pathway.

Tian Y, Hu X, Wang X, Huang Y, Hao J, Guo Y Discov Oncol. 2024; 15(1):732.

PMID: 39614999 PMC: 11608201. DOI: 10.1007/s12672-024-01625-6.


mA-Mediated Upregulation of lncRNA CHASERR Promotes the Progression of Glioma by Modulating the miR-6893-3p/TRIM14 Axis.

Wu X, Fu M, Ge C, Zhou H, Huang H, Zhong M Mol Neurobiol. 2024; 61(8):5418-5440.

PMID: 38193984 DOI: 10.1007/s12035-023-03911-w.


[miRNA-128-3p inhibits malignant behavior of glioma cells by downregulating KLHDC8A expression].

Yu Z, Li J, Jiang J, Li Y, Lin L, Xia Y Nan Fang Yi Ke Da Xue Xue Bao. 2023; 43(9):1447-1459.

PMID: 37814858 PMC: 10563106. DOI: 10.12122/j.issn.1673-4254.2023.09.01.


mA-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma.

Zhu X, Wu X, Yang H, Xu Q, Zhang M, Liu X Biol Direct. 2023; 18(1):27.

PMID: 37270527 PMC: 10239147. DOI: 10.1186/s13062-023-00386-6.


Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients.

Allegra A, Murdaca G, Mirabile G, Gangemi S Biomedicines. 2023; 11(5).

PMID: 37238995 PMC: 10215686. DOI: 10.3390/biomedicines11051325.


References
1.
Hamivand Z, Haddadi G, Fardid R . Expression of Bax and Bcl2 Genes in Peripheral Blood Lymphocytes of Patients with Differentiated Thyroid Cancer. J Med Phys. 2018; 43(1):41-45. PMC: 5879822. DOI: 10.4103/jmp.JMP_104_17. View

2.
Bredel M, Bredel C, Juric D, Harsh G, Vogel H, Recht L . Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. Cancer Res. 2005; 65(19):8679-89. DOI: 10.1158/0008-5472.CAN-05-1204. View

3.
Zhang B, Shen R, Cheng S, Feng L . Immune microenvironments differ in immune characteristics and outcome of glioblastoma multiforme. Cancer Med. 2019; 8(6):2897-2907. PMC: 6558448. DOI: 10.1002/cam4.2192. View

4.
Pandey V, Bhaskara V, Prakash Babu P . Implications of mitogen-activated protein kinase signaling in glioma. J Neurosci Res. 2015; 94(2):114-27. DOI: 10.1002/jnr.23687. View

5.
Tang Z, Kang B, Li C, Chen T, Zhang Z . GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019; 47(W1):W556-W560. PMC: 6602440. DOI: 10.1093/nar/gkz430. View